Skip to main content

CUTERA INC. Value Stock - Dividend - Research Selection

Cutera

ISIN: US2321091082 , WKN: A0B9QG

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Cutera, Inc., a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating. It also provides excel V, a vascular and benign pigmented lesion treatment platform; xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin rejuvenation by treating discoloration, fine lines, and laxity; Juliet, a laser system for vaginal health; and Secret RF, a fractional radio frequency microneedling device for skin rejuvenation. In addition, the company offers GenesisPlus system, a laser product for use in the temporary increase of clear nails in patients with onychomycosis, as well as for the treatment of fine wrinkles, diffuse redness, and rosacea; and CoolGlide, as well as myQ, a third-party sourced system for the Japanese market. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills and marketing brochures through the Internet. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, physicians performing aesthetic treatments in non-medical offices, and other qualified practitioners, as well as for physicians offering aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Largest borrow rate increases among liquid names

2024-05-29
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Cutera, Inc. Investor Alert (NASDAQ: CUTR): Schubert Jonckheer & Kolbe LLP Investigating Potential Claims Against the Company's Officers and Directors

2024-05-21
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Insider Sale at Cutera Inc (CUTR): EVP, Chief Technology Officer Michael Karavitis Sells 63,603 ...

2024-05-16
On May 16, 2024, Michael Karavitis, the Executive Vice President and Chief Technology Officer of Cutera Inc (NASDAQ:CUTR), sold 63,603 shares of the company.

Cutera, Inotiv, Treace Medical Concepts among healthcare movers

2024-05-14
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Cutera (CUTR) was downgraded to a Hold Rating at Maxim Group

2024-05-11
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Cutera, Inc. (NASDAQ:CUTR) Q1 2024 Earnings Call Transcript

2024-05-10
Cutera, Inc. (NASDAQ:CUTR) Q1 2024 Earnings Call Transcript May 9, 2024 Cutera, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. This is the conference operator. Welcome to the Cutera, Inc. First Quarter 2024 Results […]

Piper Sandler Keeps Their Hold Rating on Cutera (CUTR)

2024-05-10
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Cutera, Inc. (CUTR) Q1 2024 Earnings Call Transcript

2024-05-09
Cutera, Inc. (NASDAQ:NASDAQ:CUTR) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ETCompany ParticipantsGreg Barker - VP of Finance and IRTaylor Harris...

Cutera (CUTR) Reports Q1 Loss, Tops Revenue Estimates

2024-05-09
Cutera (CUTR) delivered earnings and revenue surprises of 6.42% and 4.38%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Cutera Announces First Quarter 2024 Financial Results

2024-05-09
BRISBANE, Calif., May 09, 2024--Cutera, Inc. (Nasdaq: CUTR) ("Cutera" or the "Company"), a leading provider of aesthetic and dermatology solutions, today reported financial results for the first quarter ended March 31, 2024.